查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424096

双胍市场、份额、规模、趋势、行业分析报告：按类型、分销管道、地区、细分市场预测，2024-2032

Biguanides Market Share, Size, Trends, Industry Analysis Report, By Type (Metformin, Phenformin, Others); By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球双胍类药物市场规模预计将达到61.9亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

持续努力的重点是配方创新、探索联合疗法以及扩大双胍类药物在糖尿病治疗中的使用。 提高临床疗效、安全性和病患治疗效果的努力体现在对新型药物传递系统和製剂的探索中。 此外，为了扩大双胍类药物的治疗范围，我们也正在研究其在血糖控制以外的心臟代谢系统中的潜在用途。 製药公司和学术机构之间的合作研究正在推动创新，并确保持续的研究有助于双胍类药物在动态的抗糖尿病治疗领域中的持续相关性。

远距医疗整合是双胍类市场成长的驱动力。 随着糖尿病管理向个人化护理发展，远距医疗平台简化了远距患者监测，以获得更好的结果。 即时追踪血糖水平和药物依从性可以提高双胍药物的有效性，尤其是在糖尿病的治疗中。 虚拟就诊可以快速调整药物治疗方案并鼓励患者参与。 这种整合不仅改善了患者护理，还为正在进行的糖尿病管理研究提供了宝贵的数据。 远距医疗提供的便利性将提高患者的依从性，刺激对双胍药物的需求，并推动市场扩张。

以患者为中心的配方正在推动双胍市场的扩张。 与个人化医疗保健的趋势一致，这些量身定制的配方，包括缓释选项，正在增加双胍类药物的吸引力和功效。 最大限度地减少副作用并简化给药方案，以提高用药依从性并优先考虑患者的舒适度和依从性。 提高满意度和药物依从性不仅可以优化治疗结果，还可以增加双胍类药物的市场需求。

联合疗法透过探索双胍药物与其他治疗类别之间的协同作用，正在推动双胍市场的成长。 这项研究和开发为提高治疗效果提供了新的机会。 将双胍类药物与胰岛素增敏药物等补充药物合併使用可以改善血糖控制并最大限度地减少副作用。 该策略不仅解决了糖尿病的多方面性质，而且还为患者提供了多样化的治疗选择。 投资开创性联合疗法的製药公司具有策略性定位，可以利用不断发展的糖尿病管理格局，并透过全面且客製化的解决方案来推进双胍类药物市场。

双胍市场报告要点

2023年，二甲双胍凭藉其功效、安全性和实惠的价格占据了很大的市场份额。

到 2023 年，由于患者取得方便且可获得性广泛，零售药局业务占据了很大的收入份额。

2023年，由于糖尿病患者增加和人口老化，北美地区将主导全球市场。

市场包括阿斯特捷利康、拜耳股份公司、勃林格殷格翰、雷迪博士实验室、礼来公司、葛兰素史克和辉瑞公司。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第4章全球双胍市场洞察

  • 双胍市场-产业概况
  • 双胍市场动态
    • 推动者和机会
      • 第一线治疗预计将刺激对该产品的需求
      • 2 型糖尿病的激增预计将推动市场成长
    • 抑制因素和挑战
      • 副作用的普遍存在可能会阻碍市场成长
  • 杵分析
  • 双胍行业趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第5章全球双胍市场，依类型

  • 主要发现
  • 简介
  • 二甲双胍
  • 苯乙双胍
  • 其他

第 6 章全球双胍市场（依分销通路）

  • 主要发现
  • 简介
  • 零售药局
  • 医院药房
  • 其他

第 7 章全球双胍市场（按地区）

  • 主要发现
  • 简介
    • 双胍市场评估，地区，2019-2032
  • 双胍市场 - 北美
    • 北美：双胍类市场，依通路划分，2019-2032 年
    • 北美：双胍类市场，依类型，2019-2032 年
    • 双胍市场-美国
    • 双胍市场 - 加拿大
  • 双胍市场 - 欧洲
    • 欧洲：双胍类市场，依通路划分，2019-2032 年
    • 欧洲：双胍类市场，依类型，2019-2032 年
    • 双胍市场 - 英国
    • 双胍市场 - 法国
    • 双胍市场 - 德国
    • 双胍市场-义大利
    • 双胍市场 - 西班牙
    • 双胍市场 - 荷兰
    • 双胍市场 - 俄罗斯
  • 双胍市场 - 亚太地区
    • 亚太地区：双胍类市场，依通路划分，2019-2032 年
    • 亚太地区：双胍类市场，依类型，2019-2032 年
    • 双胍市场 - 中国
    • 双胍市场-印度
    • 双胍市场 - 马来西亚
    • 双胍市场-日本
    • 双胍市场-印度尼西亚
    • 双胍市场-韩国
  • 双胍类市场 - 中东和非洲
    • 中东与非洲：双胍类市场，依通路划分，2019-2032 年
    • 中东和非洲：双胍类市场，按类型，2019-2032 年
    • 双胍市场-沙乌地阿拉伯
    • 双胍市场 - 阿拉伯联合大公国
    • 双胍市场——以色列
    • 双胍市场-南非
  • 双胍市场 - 拉丁美洲
    • 拉丁美洲：双胍类市场，依通路划分，2019-2032 年
    • 拉丁美洲：双胍类市场，按类型，2019-2032 年
    • 双胍市场 - 墨西哥
    • 双胍市场－巴西
    • 双胍市场-阿根廷

第8章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第9章公司简介

  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Novartis
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Cadila
Product Code: PM4410

The global Biguanides market size is expected to reach USD 6.19 billion by 2032, according to a new study by Polaris Market Research. The report "Biguanides Market Share, Size, Trends, Industry Analysis Report, By Type (Metformin, Phenformin, Others); By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Ongoing efforts focus on innovating formulations, exploring combination therapies, and expanding the applications of biguanides in diabetes care. The commitment to enhancing clinical efficacy, safety, and patient outcomes is evident in the exploration of novel drug delivery systems and formulations. Research also investigates potential cardiometabolic benefits beyond glycemic control, broadening the therapeutic scope of biguanides. Collaborations between pharmaceutical entities and academic institutions drive innovation, ensuring that ongoing research contributes to the sustained significance of biguanides in the dynamic landscape of antidiabetic therapies.

Telehealth integration is a driving force behind the growth of the biguanides market. As diabetes management evolves towards personalized care, telehealth platforms streamline remote patient monitoring for better outcomes. Real-time tracking of blood glucose levels and medication adherence enhances the efficacy of biguanides, particularly in diabetes treatment. Virtual consultations enable prompt adjustments to medication regimens, fostering patient engagement. This integration not only improves patient care but also contributes valuable data for ongoing research in diabetes management. The convenience offered by telehealth enhances patient compliance, fueling the demand for biguanides and propelling market expansion.

Patient-centric formulations are driving the expansion of the biguanides market. Aligned with the trend towards personalized healthcare, these tailored formulations, including extended-release options, boost the appeal and efficacy of biguanides. They enhance medication adherence by minimizing side effects and simplifying dosing regimens, prioritizing patient comfort and compliance. Improved satisfaction and adherence not only optimize treatment outcomes but also heighten the market desirability of biguanides.

Combination therapies are propelling biguanides market growth by exploring synergies between biguanides and other therapeutic classes. This research and development avenue offers novel opportunities for heightened treatment efficacy. By combining biguanides with complementary drugs like insulin sensitizers, there's potential for improved glycemic control and minimized side effects. This strategy not only tackles the multifaceted nature of diabetes but also diversifies treatment options for patients. Pharmaceutical companies investing in pioneering combination therapies strategically position themselves to leverage the evolving diabetes management landscape, advancing the biguanides market with comprehensive and tailored solutions.

Biguanides Market Report Highlights

In 2023, the metformin segment accounted for significant market share owing to efficacy, safety profile, and affordability.

In 2023, the retail pharmacy segment held significant revenue share owing to convenient access for patients and widespread availability.

In 2023, North America region dominated the global market due to rising diabetes cases, and an aging population.

The market is highly competitive owing to the existence of market players with a global presence, including AstraZeneca, Bayer AG, Boehringer Ingelheim, Dr. Reddy's Laboratories, Eli Lilly and Company, GlaxoSmithKline, Pfizer Inc., and Sanofi among others.

Polaris Market Research has segmented the Biguanides market report based on type, distribution channel, and region:

Biguanides, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Metformin
  • Phenformin
  • Others

Biguanides, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Others

Biguanides, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biguanides Market Insights

  • 4.1. Biguanides Market - Industry Snapshot
  • 4.2. Biguanides Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. First-Line Treatment is projected to spur the product demand
      • 4.2.1.2. Surging prevalence of type 2 diabetes is expected to drive market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Prevalence of side effects is likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Biguanides Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Biguanides Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biguanides, by Type, 2019-2032 (USD Billion)
  • 5.3. Metformin
    • 5.3.1. Global Biguanides Market, by Metformin, by Region, 2019-2032 (USD Billion)
  • 5.4. Phenformin
    • 5.4.1. Global Biguanides Market, by Phenformin, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Biguanides Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Biguanides Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 6.3. Retail Pharmacy
    • 6.3.1. Global Biguanides Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
  • 6.4. Hospital Pharmacy
    • 6.4.1. Global Biguanides Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Biguanides Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Biguanides Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Biguanides Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Biguanides Market - North America
    • 7.3.1. North America: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.3.2. North America: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.3.3. Biguanides Market - U.S.
      • 7.3.3.1. U.S.: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.3.4. Biguanides Market - Canada
      • 7.3.4.1. Canada: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • 7.4. Biguanides Market - Europe
    • 7.4.1. Europe: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.3. Biguanides Market - UK
      • 7.4.3.1. UK: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.4. Biguanides Market - France
      • 7.4.4.1. France: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.5. Biguanides Market - Germany
      • 7.4.5.1. Germany: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.6. Biguanides Market - Italy
      • 7.4.6.1. Italy: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.7. Biguanides Market - Spain
      • 7.4.7.1. Spain: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.8. Biguanides Market - Netherlands
      • 7.4.8.1. Netherlands: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.9. Biguanides Market - Russia
      • 7.4.9.1. Russia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • 7.5. Biguanides Market - Asia Pacific
    • 7.5.1. Asia Pacific: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.3. Biguanides Market - China
      • 7.5.3.1. China: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.4. Biguanides Market - India
      • 7.5.4.1. India: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.5. Biguanides Market - Malaysia
      • 7.5.5.1. Malaysia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.6. Biguanides Market - Japan
      • 7.5.6.1. Japan: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.7. Biguanides Market - Indonesia
      • 7.5.7.1. Indonesia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.8. Biguanides Market - South Korea
      • 7.5.8.1. South Korea: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • 7.6. Biguanides Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.6.3. Biguanides Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.6.4. Biguanides Market - UAE
      • 7.6.4.1. UAE: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.6.5. Biguanides Market - Israel
      • 7.6.5.1. Israel: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.6.6. Biguanides Market - South Africa
      • 7.6.6.1. South Africa: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • 7.7. Biguanides Market - Latin America
    • 7.7.1. Latin America: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.7.3. Biguanides Market - Mexico
      • 7.7.3.1. Mexico: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.7.4. Biguanides Market - Brazil
      • 7.7.4.1. Brazil: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.7.5. Biguanides Market - Argentina
      • 7.7.5.1. Argentina: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Biguanides Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. AstraZeneca
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Bayer AG
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Boehringer Ingelheim
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bristol Myers Squibb
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Dr. Reddy's Laboratories
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Eli Lilly and Company
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. GlaxoSmithKline
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Lupin Pharmaceuticals, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Merck & Co., Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Novartis
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Pfizer Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Sanofi
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Sun Pharmaceutical Industries Ltd.
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Teva Pharmaceutical Industries Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Zydus Cadila
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development

List of Tables

  • Table 1 Global Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 2 Global Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Biguanides Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 5 North America: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 U.S.: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 9 Canada: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Europe: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 12 UK: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 UK: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 14 France: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 15 France: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 Germany: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 Italy: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 21 Spain: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Russia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 28 China: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 China: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 30 India: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 India: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Japan: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 39 South Korea: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 45 UAE: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Israel: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 South Africa: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 51 Latin America: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Mexico: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Brazil: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 57 Argentina: Biguanides Market, by Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Biguanides Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Distribution Channel
  • Figure 7 Global Biguanides Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Type
  • Figure 9 Global Biguanides Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10 Biguanides Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Biguanides Market